FR2182952B1 - - Google Patents

Info

Publication number: FR2182952B1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

FR7313061A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-04-11

Filing date

1973-04-11

Publication date

1975-10-31

1973-04-11 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

1973-12-14 Publication of FR2182952A1 publication Critical patent/FR2182952A1/fr

1975-10-31 Application granted granted Critical

1975-10-31 Publication of FR2182952B1 publication Critical patent/FR2182952B1/fr

Status Expired legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FR7313061A 1972-04-11 1973-04-11 Expired FR2182952B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US00243480A US3816446A (en)	1972-04-11	1972-04-11	(alpha-(3-trifluoromethylphenoxy)-4-chlorobenzyl)heterocycles

Publications (2)

Publication Number	Publication Date
FR2182952A1 FR2182952A1 (fr)	1973-12-14
FR2182952B1 true FR2182952B1 (fr)	1975-10-31

Family

ID=22918919

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR7313061A Expired FR2182952B1 (fr)	1972-04-11	1973-04-11

Country Status (9)

Country	Link
US (1)	US3816446A (fr)
JP (1)	JPS5030620B2 (fr)
CH (1)	CH589636A5 (fr)
DE (1)	DE2318002A1 (fr)
DK (1)	DK136976B (fr)
FR (1)	FR2182952B1 (fr)
GB (1)	GB1388790A (fr)
NL (1)	NL7304333A (fr)
SE (1)	SE380524B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3953465A (en) *	1972-04-11	1976-04-27	Merck & Co., Inc.	2-[α-(3-Trifluoromethylphenoxyl)-4-chlorobenzyl]oxazole and methods for preparing the same
US3953490A (en) *	1972-07-13	1976-04-27	Merck & Co., Inc.	Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile
JPS50116306U (fr) *	1974-03-05	1975-09-22
JPS50137193U (fr) *	1974-04-25	1975-11-12
JPS5111502A (ja) *	1974-07-19	1976-01-29	Matsushita Electric Ind Co Ltd	Senkyokusochi
JPS544877Y2 (fr) *	1976-12-03	1979-03-01
DE3161525D1 (en) *	1980-03-05	1984-01-05	Ciba Geigy Ag	Herbicidally active 2-nitro-5-phenoxyphenyl oxazoles, oxazines, imidazoles, pyrimidines and thiazoles, their preparation and their use
US4870187A (en) *	1988-08-23	1989-09-26	Bristol-Myers Company	Antihypercholesterolemic tetrazol-1-yl compounds
FR2766821A1 (fr) *	1997-07-29	1999-02-05	Sanofi Sa	Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
WO2002064094A2 (fr) *	2001-02-09	2002-08-22	Merck & Co., Inc.	Acides 2-aryloxy-2-arylalcanoïques utilisés pour le traitement du diabètes et des troubles lipidiques
RU2006133284A (ru) *	2004-02-18	2008-03-27	Метаболекс	Альфа-(трифторметилзамещенные арилокси, ариламино, арилтио или арилметил)трифторметилзамещенные фенилуксусные кислоты и производные как противодиабетические средства
US7323480B2 (en)	2004-05-25	2008-01-29	Metabolex, Inc.	Substituted triazoles as modulators of PPAR and methods of their preparation

1972
- 1972-04-11 US US00243480A patent/US3816446A/en not_active Expired - Lifetime
1973
- 1973-03-28 SE SE7304363A patent/SE380524B/xx unknown
- 1973-03-28 DK DK169573AA patent/DK136976B/da unknown
- 1973-03-28 NL NL7304333A patent/NL7304333A/xx not_active Application Discontinuation
- 1973-04-05 GB GB1636273A patent/GB1388790A/en not_active Expired
- 1973-04-06 JP JP48038858A patent/JPS5030620B2/ja not_active Expired
- 1973-04-10 DE DE2318002A patent/DE2318002A1/de active Pending
- 1973-04-11 FR FR7313061A patent/FR2182952B1/fr not_active Expired
- 1973-04-11 CH CH519173A patent/CH589636A5/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
SE380524B (sv)	1975-11-10
NL7304333A (fr)	1973-10-15
US3816446A (en)	1974-06-11
CH589636A5 (fr)	1977-07-15
DK136976B (da)	1977-12-27
JPS497275A (fr)	1974-01-22
DE2318002A1 (de)	1973-10-31
FR2182952A1 (fr)	1973-12-14
DK136976C (fr)	1978-06-05
GB1388790A (en)	1975-03-26
JPS5030620B2 (fr)	1975-10-02

Legal Events

Date	Code	Title	Description
1980-02-22	ST	Notification of lapse

Publication	Publication Date	Title
DK136976C (fr)	1978-06-05
CH567048A5 (fr)	1975-09-30
CH562345A5 (fr)	1975-05-30
BG18194A1 (fr)	1974-10-25
CH562478A5 (fr)	1975-05-30
CH578036A5 (fr)	1976-07-30
CH562942A5 (fr)	1975-06-13
CH579551A5 (fr)	1976-09-15
CH563025A5 (fr)	1975-06-13
CH563053A5 (fr)	1975-06-13
CH563639A5 (fr)	1975-06-30
CH563641A5 (fr)	1975-06-30
AU480156A (fr)	1974-11-28
CH563689A5 (fr)	1975-06-30
CH561966A5 (fr)	1975-05-15
CH564726A5 (fr)	1975-07-31
CH567474A5 (fr)	1975-10-15
CH566781A5 (fr)	1975-09-30
CH563768A5 (fr)	1975-07-15
CH579257A5 (fr)	1976-08-31
CH567149A5 (fr)	1975-09-30
CH576953A5 (fr)	1976-06-30
CH569413A5 (fr)	1975-11-28
CH565686A5 (fr)	1975-08-29
BG19033A1 (fr)	1975-04-30